A comparative study of esketamine-dexmedetomidine and sufentanil-dexmedetomidine for sedation and analgesia in lung tumor percutaneous radiofrequency ablation (PRFA): a randomized double-blind clinical trial

A comparative study of esketamine-dexmedetomidine and sufentanil-dexmedetomidine for sedation and analgesia in lung tumor percutaneous radiofrequency ablation (PRFA): a randomized double-blind clinical trial

Abstract Objective To observe and evaluate the effectiveness and safety of Esketamine or Sufentanil combined with Dexmedetomidine for sedation and analgesia in lung tumor percutaneous radiofrequency ablation (PRFA) to provide a clinical basis for the optimization of sedation and analgesia in lung tu...

Full description

Bibliographic Details
Main Authors: Zhonglan Lin, Shuxin Li, Yun Zhou, Xinlei Lu, Bin Yang, Zhengwei Yu, Yuan Cheng, Jianliang Sun
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Anesthesiology
Subjects:
Esketamine
Dexmedetomidine
Sedation
Analgesia
Lung tumor radiofrequency ablation
Online Access:https://doi.org/10.1186/s12871-023-02266-y

Internet

https://doi.org/10.1186/s12871-023-02266-y

Similar Items